MarketPeel
Insider Trading Intelligence
RF

Raymond J. Furey

RIGL
EVP, GC, CCO & CORP SEC · RIGEL PHARMACEUTICALS INC · CIK 0001577899
FILING MIX · LIFETIME69%/31%
BUYS
11
SELLS
5
TOTAL VALUE
$351.5K
COMPANIES
1
ACTIVE SINCE
Jan 2024
HOLDINGS NOW
7,394
AVG SELL PX
$31.44
TRADE KIND
SHOWING 16 / 16
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Raymond J. Furey, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%-4.47%+0.22%-4.69%-4.69%
14d2+100.00%-5.15%+1.53%-6.67%-6.67%
30d2+100.00%-7.86%-4.76%-3.10%-3.10%
60d2+100.00%-21.37%-16.03%-5.35%-5.35%
90d2+100.00%-14.22%-6.66%-7.56%-7.56%
180d2+50.00%+3.97%+4.99%-1.02%-1.02%
1y2+0.00%+56.50%+13.43%+43.07%+43.07%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RIGL · 7,394 shares · as of Jun 17, 2026
053,500107,000160,500214,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 5 sellsCOVERAGE · 10 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,3947,394Jun 17, 2026Jun 22, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP, GC, CCO & Corp Sec
877$29.86$26.2K50,936Jun 1, 2026Jun 3, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
19,49751,813Feb 17, 2026Feb 19, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP, GC, CCO & Corp Sec
3,546$34.62$122.8K32,316Feb 10, 2026Feb 12, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP, GC, CCO & Corp Sec
3,968$36.01$142.9K35,862Feb 2, 2026Feb 4, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,3947,394Sep 15, 2025Sep 17, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,8507,850Mar 17, 2025Mar 19, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
9,3759,375Mar 17, 2025Mar 19, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP, GC, CCO & Corp Sec
1,339$21.93$29.4K38,830Feb 5, 2025Feb 6, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP, GC, CCO & Corp Sec
1,448$20.92$30.3K40,169Feb 4, 2025Feb 6, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
14,78814,788Jan 29, 2025Jan 31, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
19,71741,617Jan 29, 2025Jan 31, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
93,75093,750Feb 28, 2024Mar 1, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
78,50078,500Feb 28, 2024Mar 1, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
209,000214,000Jan 23, 2024Jan 25, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
157,000157,000Jan 23, 2024Jan 25, 2024View →
Other insiders · RIGL
Loading peer insiders…
About this filer
CIK 0001577899
ROLE
EVP, GC, CCO & Corp Sec
PRIMARY
RIGL
COMPANIES
1
ACTIVE SINCE
Jan 2024
MARKETPEEL · /INSIDER/0001577899DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback